Loss of Optineurin in vivo results in elevated cell death and alters axonal trafficking dynamics

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Paulus, Jeremiah D ^a   Link, Brian A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OPTINEURIN; EYE PROTEIN; OPTN PROTEIN, HUMAN; OPTN PROTEIN, MOUSE; TRANSCRIPTION FACTOR IIIA;

ADULT; ANIMAL TISSUE; ARTICLE; AXONAL TRAFFICKING; CELL DEATH; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; EMBRYO; FILOPODIUM; GOLGI COMPLEX; HEAD; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; NERVE FIBER; NEURAL CREST CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PIGMENT CELL; RETINA; ZEBRA FISH; AMINO ACID SEQUENCE; ANIMAL; APOPTOSIS; AXON; CELL MOTION; CHEMISTRY; CONSERVED SEQUENCE; CYTOLOGY; DEFICIENCY; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; MUTATION; NEURAL CREST; NONMAMMALIAN EMBRYO; PROTEIN TERTIARY STRUCTURE; TRANSPORT AT THE CELLULAR LEVEL;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; AXONS; BIOLOGICAL TRANSPORT; CELL MOVEMENT; CONSERVED SEQUENCE; EMBRYO, NONMAMMALIAN; EYE PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NEURAL CREST; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTOR TFIIIA; ZEBRAFISH;

EID: 84908045074     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109922     Document Type: Article

References (117)

1. Rezaie T, Child A, Hitchings R, Brice G, Miller L, et al. (2002) Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295: 1077-1079. doi:10.1126/science.1066901.
2. Leung YF, Fan BJ, Lam DSC, Lee WS, Tam POS, et al. (2003) Different optineurin mutation pattern in primary open-angle glaucoma. Invest Ophthalmol Vis Sci 44: 3880-3884.
3. Xiao Z, Meng Q, Tsai JC, Yuan H, Xu N, et al. (2009) A novel optineurin genetic mutation associated with open-angle glaucoma in a Chinese family. Mol Vis 15: 1649-1654.
4. Ayala-Lugo RM, Pawar H, Reed DM, Lichter PR, Moroi SE, et al. (2007) Variation in optineurin (OPTN) allele frequencies between and within populations. Mol Vis 13: 151-163.
5. Funayama T, Mashima Y, Ohtake Y, Ishikawa K, Fuse N, et al. (2006) SNPs and interaction analyses of noelin 2, myocilin, and optineurin genes in Japanese patients with open-angle glaucoma. Invest Ophthalmol Vis Sci 47: 5368-5375. doi:10.1167/iovs.06-0196.
6. Hauser MA, Sena DF, Flor J, Walter J, Auguste J, et al. (2006) Distribution of optineurin sequence variations in an ethnically diverse population of low-tension glaucoma patients from the United States. J Glaucoma 15: 358-363. doi:10.1097/01.ijg.0000212255.17950.42.
7. Yasuda N, Nakamoto K, Funayama T, Mashima Y (2006) [Low penetrance of His26Asp mutation in the optineurin gene in a Japanese family with normal-tension glaucoma]. Nippon Ganka Gakkai Zasshi 110: 594-600.
8. Sripriya S, Nirmaladevi J, George R, Hemamalini A, Baskaran M, et al. (2006) OPTN gene: profile of patients with glaucoma from India. Mol Vis 12: 816-820.
9. Yao H, Cheng C, Fan B, Tam O, Tham C, et al. (2006) [Polymorphisms of myocilin and optineurin in primary open angle glaucoma patients]. Zhonghua Yi Xue Za Zhi 86: 554-559.
10. Rakhmanov VV, Nikitina NI, Zakharova FM, Astakhov IS, Kvasova MD, et al. (2005) [Mutations and polymorphisms in the genes for myocilin and optineur in as the risk factors of primary open-angle glaucoma]. Genetika 41: 1567-1574.
11. Mukhopadhyay A, Komatireddy S, Acharya M, Bhattacharjee A, Mandal AK, et al. (2005) Evaluation of Optineurin as a candidate gene in Indian patients with primary open angle glaucoma. Mol Vis 11: 792-797.
12. Fan BJ, Wang DY, Fan DSP, Tam POS, Lam DSC, et al. (2005) SNPs and interaction analyses of myocilin, optineurin, and apolipoprotein E in primary open angle glaucoma patients. Mol Vis 11: 625-631.
13. Weisschuh N, Neumann D, Wolf C, Wissinger B, Gramer E (2005) Prevalence of myocilin and optineurin sequence variants in German normal tension glaucoma patients. Mol Vis 11: 284-287.
14. Funayama T, Ishikawa K, Ohtake Y, Tanino T, Kurosaka D, et al. (2004) Variants in optineurin gene and their association with tumor necrosis factor-alpha polymorphisms in Japanese patients with glaucoma. Invest Ophthalmol Vis Sci 45: 4359-4367. doi:10.1167/iovs.03-1403.
15. Baird PN, Richardson AJ, Craig JE, Mackey DA, Rochtchina E, et al. (2004) Analysis of optineurin (OPTN) gene mutations in subjects with and without glaucoma: the Blue Mountains Eye Study. Clin Experiment Ophthalmol 32: 518-522. doi:10.1111/j.1442-9071.2004.00886.x.
16. Willoughby CE, Chan LLY, Herd S, Billingsley G, Noordeh N, et al. (2004) Defining the pathogenicity of optineurin in juvenile open-angle glaucoma. Invest Ophthalmol Vis Sci 45: 3122-3130. doi:10.1167/iovs.04-0107.
17. Aung T, Rezaie T, Okada K, Viswanathan AC, Child AH, et al. (2005) Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene. Invest Ophthalmol Vis Sci 46: 2816-2822. doi:10.1167/iovs.04-1133.
18. Fuse N, Takahashi K, Akiyama H, Nakazawa T, Seimiya M, et al. (2004) Molecular genetic analysis of optineurin gene for primary open-angle and normal tension glaucoma in the Japanese population. J Glaucoma 13: 299-303.
19. Aung T, Ebenezer ND, Brice G, Child AH, Prescott Q, et al. (2003) Prevalence of optineurin sequence variants in adult primary open angle glaucoma: implications for diagnostic testing. J Med Genet 40: e101.
20. Patel HY, Richards AJ, De Karolyi B, Best SJ, Danesh-Meyer HV, et al. (2012) Screening glaucoma genes in adult glaucoma suggests a multiallelic contribution of CYP1B1 to open-angle glaucoma phenotypes. Clin Experiment Ophthalmol 40: e208-217. doi:10.1111/j.1442-9071.2011.02714.x.
21. Belzil VV, Daoud H, Desjarlais A, Bouchard JP, Dupré N, et al. (2011) Analysis of OPTN as a causative gene for amyotrophic lateral sclerosis. Neurobiol Aging 32: 555.e13-14. doi:10.1016/j.neurobiolaging.2010.10.001.
22. Millecamps S, Boillée S, Chabrol E, Camu W, Cazeneuve C, et al. (2011) Screening of OPTN in French familial amyotrophic lateral sclerosis. Neurobiol Aging 32: 557.e11-13. doi:10.1016/j.neurobiolaging.2010.11.005.
23. Ito H, Nakamura M, Komure O, Ayaki T, Wate R, et al. (2011) Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation. Acta Neuropathol (Berl) 122: 223-229. doi:10.1007/s00401-011-0842-y.
24. Sugihara K, Maruyama H, Kamada M, Morino H, Kawakami H (2011) Screening for OPTN mutations in amyotrophic lateral sclerosis in a mainly Caucasian population. Neurobiol Aging 32: 1923.e9-10. doi:10.1016/j.neurobiolaging.2011.03.024.
25. Del Bo R, Tiloca C, Pensato V, Corrado L, Ratti A, et al. (2011) Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82: 1239-1243. doi:10.1136/jnnp.2011.242313.
26. Tümer Z, Bertelsen B, Gredal O, Magyari M, Nielsen KC, et al. (2012) Novel heterozygous nonsense mutation of the OPTN gene segregating in a Danish family with ALS. Neurobiol Aging 33: 208.e1-5. doi:10.1016/j.neurobiolaging.2011.07.001.
27. Iida A, Hosono N, Sano M, Kamei T, Oshima S, et al. (2012) Optineurin mutations in Japanese amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 83: 233-235. doi:10.1136/jnnp.2010.234963.
28. Van Blitterswijk M, van Vught PWJ, van Es MA, Schelhaas HJ, van der Kooi AJ, et al. (2012) Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients. Neurobiol Aging 33: 1016.e1-7. doi:10.1016/j.neurobiolaging.2011.05.019.
29. Lattante S, Conte A, Zollino M, Luigetti M, Del Grande A, et al. (2012) Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease. Neurology 79: 66-72. doi:10.1212/WNL.0b013e31825dceca.
30. Maruyama H, Morino H, Ito H, Izumi Y, Kato H, et al. (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465: 223-226. doi:10.1038/nature08971.
31. Naruse H, Takahashi Y, Kihira T, Yoshida S, Kokubo Y, et al. (2012) Mutational analysis of familial and sporadic amyotrophic lateral sclerosis with OPTN mutations in Japanese population. Amyotroph Lateral Scler Off Publ World Fed Neurol Res Group Mot Neuron Dis 13: 562-566. doi:10.3109/17482968.2012.684213.
32. Weishaupt JH, Waibel S, Birve A, Volk AE, Mayer B, et al. (2013) A novel optineurin truncating mutation and three glaucoma-associated missense variants in patients with familial amyotrophic lateral sclerosis in Germany. Neurobiol Aging 34: 1516.e9-15. doi:10.1016/j.neurobiolaging.2012.09.007.
33. Chiò A, Calvo A, Mazzini L, Cantello R, Mora G, et al. (2012) Extensive genetics of ALS: a population-based study in Italy. Neurology 79: 1983-1989. doi:10.1212/WNL.0b013e3182735d36.
34. Czell D, Andersen PM, Neuwirth C, Morita M, Weber M (2013) Progressive aphasia as the presenting symptom in a patient with amyotrophic lateral sclerosis with a novel mutation in the OPTN gene. Amyotroph Lateral Scler Front Degener 14: 138-140. doi:10.3109/21678421.2012.756525.
35. Ueno H, Kobatake K, Matsumoto M, Morino H, Maruyama H, et al. (2011) Severe brain atrophy after long-term survival seen in siblings with familial amyotrophic lateral sclerosis and a mutation in the optineurin gene: a case series. J Med Case Reports 5: 573. doi:10.1186/1752-1947-5-573.
36. Albagha OME, Wani SE, Visconti MR, Alonso N, Goodman K, et al. (2011) Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet 43: 685-689. doi:10.1038/ng.845.
37. Michou L, Conceic¸ão N, Morissette J, Gagnon E, Miltenberger-Miltenyi G, et al. (2012) Genetic association study of UCMA/GRP and OPTN genes (PDB6 locus) with Paget's disease of bone. Bone 51: 720-728. doi:10.1016/j.bone.2012.06.028.
38. Chung PYJ, Beyens G, Boonen S, Papapoulos S, Geusens P, et al. (2010) The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes. Hum Genet 128: 615-626. doi:10.1007/s00439-010-0888-2.
39. Osawa T, Mizuno Y, Fujita Y, Takatama M, Nakazato Y, et al. (2011) Optineurin in neurodegenerative diseases. Neuropathol Off J Jpn Soc Neuropathol 31: 569-574. doi:10.1111/j.1440-1789.2011.01199.x.
40. Ito H, Fujita K, Nakamura M, Wate R, Kaneko S, et al. (2011) Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease. Acta Neuropathol (Berl) 121: 555-557. doi:10.1007/s00401-011-0809-z.
41. Fujita K, Yoshida M, Sako W, Maeda K, Hashizume Y, et al. (2011) Brainstem and spinal cord motor neuron involvement with optineurin inclusions in proximal-dominant hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry 82: 1402-1403. doi:10.1136/jnnp-2011-300783.
42. Schwab C, Yu S, McGeer EG, McGeer PL (2012) Optineurin in Huntington's disease intranuclear inclusions. Neurosci Lett 506: 149-154. doi:10.1016/j.neulet.2011.10.070.
43. Keller BA, Volkening K, Droppelmann CA, Ang LC, Rademakers R, et al. (2012) Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism. Acta Neuropathol (Berl) 124: 733-747. doi:10.1007/s00401-012-1035-z.
44. Mori F, Tanji K, Toyoshima Y, Yoshida M, Kakita A, et al. (2012) Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington's, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease. Acta Neuropathol (Berl) 123: 747-749. doi:10.1007/s00401-012-0956-x.
45. Schwab C, Yu S, McGeer PL (2012) Optineurin is colocalized with ubiquitin in Marinesco bodies. Acta Neuropathol (Berl) 123: 289-292. doi:10.1007/s00401-011-0915-y.
46. Sudhakar C, Nagabhushana A, Jain N, Swarup G (2009) NF-kappaB mediates tumor necrosis factor alpha-induced expression of optineurin, a negative regulator of NF-kappaB. PloS One 4: e5114. doi:10.1371/journal.pone.0005114.
47. Akizuki M, Yamashita H, Uemura K, Maruyama H, Kawakami H, et al. (2013) Optineurin suppression causes neuronal cell death via NF-κB pathway. J Neurochem 126: 699-704. doi:10.1111/jnc.12326.
48. Zhu G, Wu CJ, Zhao Y, Ashwell JD (2007) Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr Biol CB 17: 1438-1443. doi:10.1016/j.cub.2007.07.041.
49. Wagner S, Carpentier I, Rogov V, Kreike M, Ikeda F, et al. (2008) Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins. Oncogene 27: 3739-3745. doi:10.1038/sj.onc.1211042.
50. Nagabhushana A, Bansal M, Swarup G (2011) Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation. PloS One 6: e17477. doi:10.1371/journal.pone.0017477.
51. Sahlender DA, Roberts RC, Arden SD, Spudich G, Taylor MJ, et al. (2005) Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis. J Cell Biol 169: 285-295. doi:10.1083/jcb.200501162.
52. Au JSY, Puri C, Ihrke G, Kendrick-Jones J, Buss F (2007) Myosin VI is required for sorting of AP-1B-dependent cargo to the basolateral domain in polarized MDCK cells. J Cell Biol 177: 103-114. doi:10.1083/jcb.200608126.
53. Del Toro D, Alberch J, Lázaro-Diéguez F, Martín-Ibáñez R, Xifró X, et al. (2009) Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus. Mol Biol Cell 20: 1478-1492. doi:10.1091/mbc.E08-07-0726.
54. Nagabhushana A, Chalasani ML, Jain N, Radha V, Rangaraj N, et al. (2010) Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant. BMC Cell Biol 11: 4. doi:10.1186/1471-2121-11-4.
55. Chi ZL, Akahori M, Obazawa M, Minami M, Noda T, et al. (2010) Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Hum Mol Genet 19: 2606-2615. doi:10.1093/hmg/ddq146.
56. Ying H, Shen X, Park B, Yue BYJT (2010) Posttranslational modifications, localization, and protein interactions of optineurin, the product of a glaucoma gene. PloS One 5: e9168. doi:10.1371/journal.pone.0009168.
57. Park BC, Shen X, Samaraweera M, Yue BYJT (2006) Studies of optineurin, a glaucoma gene: Golgi fragmentation and cell death from overexpression of wild-type and mutant optineurin in two ocular cell types. Am J Pathol 169: 1976-1989. doi:10.2353/ajpath.2006.060400.
58. Bond LM, Peden AA, Kendrick-Jones J, Sellers JR, Buss F (2011) Myosin VI and its binding partner optineurin are involved in secretory vesicle fusion at the plasma membrane. Mol Biol Cell 22: 54-65. doi:10.1091/mbc.E10-06-0553.
59. Hattula K, Peränen J (2000) FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis. Curr Biol CB 10: 1603-1606.
60. Vaibhava V, Nagabhushana A, Chalasani MLS, Sudhakar C, Kumari A, et al. (2012) Optineurin mediates a negative regulation of Rab8 by the GTPase-activating protein TBC1D17. J Cell Sci 125: 5026-5039. doi:10.1242/jcs.102327.
61. Chalasani MLS, Kumari A, Radha V, Swarup G (2014) E50K-OPTN-induced retinal cell death involves the Rab GTPase-activating protein, TBC1D17 mediated block in autophagy. PloS One 9: e95758. doi:10.1371/journal.pone.0095758.
62. Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, et al. (2011) Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333: 228-233. doi:10.1126/science.1205405.
63. Korac J, Schaeffer V, Kovacevic I, Clement AM, Jungblut B, et al. (2013) Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J Cell Sci 126: 580-592. doi:10.1242/jcs.114926.
64. Tumbarello DA, Waxse BJ, Arden SD, Bright NA, Kendrick-Jones J, et al. (2012) Autophagy receptors link myosin VI to autophagosomes to mediate Tom1-dependent autophagosome maturation and fusion with the lysosome. Nat Cell Biol 14: 1024-1035. doi:10.1038/ncb2589.
65. Kachaner D, Filipe J, Laplantine E, Bauch A, Bennett KL, et al. (2012) Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression. Mol Cell 45: 553-566. doi:10.1016/j.molcel.2011.12.030.
66. Anborgh PH, Godin C, Pampillo M, Dhami GK, Dale LB, et al. (2005) Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin. J Biol Chem 280: 34840-34848. doi:10.1074/jbc.M504508200.
67. Li X, Sapp E, Valencia A, Kegel KB, Qin ZH, et al. (2008) A function of huntingtin in guanine nucleotide exchange on Rab11. Neuroreport 19: 1643-1647. doi:10.1097/WNR.0b013e328315cd4c.
68. Sippl C, Bosserhoff AK, Fischer D, Tamm ER (2011) Depletion of optineurin in RGC-5 cells derived from retinal neurons causes apoptosis and reduces the secretion of neurotrophins. Exp Eye Res 93: 669-680. doi:10.1016/j.exer.2011.08.011.
69. Li H, Ao X, Jia J, Wang Q, Zhang Z (2011) Effects of optineurin siRNA on apoptotic genes and apoptosis in RGC-5 cells. Mol Vis 17: 3314-3325.
70. Chibalina MV, Poliakov A, Kendrick-Jones J, Buss F (2010) Myosin VI and optineurin are required for polarized EGFR delivery and directed migration. Traffic Cph Den 11: 1290-1303. doi:10.1111/j.1600-0854.2010.01101.x.
71. Gleason CE, Ordureau A, Gourlay R, Arthur JSC, Cohen P (2011) Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon β. J Biol Chem 286: 35663-35674. doi:10.1074/jbc.M111.267567.
72. Munitic I, Giardino Torchia ML, Meena NP, Zhu G, Li CC, et al. (2013) Optineurin insufficiency impairs IRF3 but not NF-κB activation in immune cells. J Immunol Baltim Md 1950 191: 6231-6240. doi:10.4049/jimmunol.1301696.
73. Meng Q, Xiao Z, Yuan H, Xue F, Zhu Y, et al. (2012) Transgenic mice with overexpression of mutated human optineurin (E50K) in the retina. Mol Biol Rep 39: 1119-1124. doi:10.1007/s11033-011-0840-0.
74. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages of embryonic development of the zebrafish. Dev Dyn Off Publ Am Assoc Anat 203: 253-310. doi:10.1002/aja.1002030302.
75. Kettleborough RNW, Busch-Nentwich EM, Harvey SA, Dooley CM, de Bruijn E, et al. (2013) A systematic genome-wide analysis of zebrafish protein-coding gene function. Nature 496: 494-497. doi:10.1038/nature11992.
76. Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, et al. (2007) The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn Off Publ Am Assoc Anat 236: 3088-3099. doi:10.1002/dvdy.21343.
77. Insinna C, Baye LM, Amsterdam A, Besharse JC, Link BA (2010) Analysis of a zebrafish dync1h1 mutant reveals multiple functions for cytoplasmic dynein 1 during retinal photoreceptor development. Neural Develop 5: 12. doi:10.1186/1749-8104-5-12.
78. Kawakami K (2004) Transgenesis and gene trap methods in zebrafish by using the Tol2 transposable element. Methods Cell Biol 77: 201-222.
79. Kawakami K (2005) Transposon tools and methods in zebrafish. Dev Dyn Off Publ Am Assoc Anat 234: 244-254. doi:10.1002/dvdy.20516.
80. Jin SW, Beis D, Mitchell T, Chen JN, Stainier DYR (2005) Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Dev Camb Engl 132: 5199-5209. doi:10.1242/dev.02087.
81. Hoffman TL, Javier AL, Campeau SA, Knight RD, Schilling TF (2007) Tfap2 transcription factors in zebrafish neural crest development and ectodermal evolution. J Exp Zoolog B Mol Dev Evol 308: 679-691. doi:10.1002/jez.b.21189.
82. Lewis ACF, Jones NS, Porter MA, Deane CM (2012) What evidence is there for the homology of protein-protein interactions? PLoS Comput Biol 8: e1002645. doi:10.1371/journal.pcbi.1002645.
83. Thisse C, Thisse B (2008) High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc 3: 59-69. doi:10.1038/nprot.2007.514.
84. Wolman MA, Liu Y, Tawarayama H, Shoji W, Halloran MC (2004) Repulsion and attraction of axons by semaphorin3D are mediated by different neuropilins in vivo. J Neurosci Off J Soc Neurosci 24: 8428-8435. doi:10.1523/JNEUROSCI.2349-04.2004.
85. Zeller J, Schneider V, Malayaman S, Higashijima S, Okamoto H, et al. (2002) Migration of zebrafish spinal motor nerves into the periphery requires multiple myotome-derived cues. Dev Biol 252: 241-256.
86. Veth KN, Willer JR, Collery RF, Gray MP, Willer GB, et al. (2011) Mutations in zebrafish lrp2 result in adult-onset ocular pathogenesis that models myopia and other risk factors for glaucoma. PLoS Genet 7: e1001310. doi:10.1371/journal.pgen.1001310.
87. Sarkar G, Cassady J, Bottema CD, Sommer SS (1990) Characterization of polymerase chain reaction amplification of specific alleles. Anal Biochem 186: 64-68.
88. Skarie JM, Link BA (2008) The primary open-angle glaucoma gene WDR36 functions in ribosomal RNA processing and interacts with the p53 stress-response pathway. Hum Mol Genet 17: 2474-2485. doi:10.1093/hmg/ddn147.
89. Winer J, Jung CK, Shackel I, Williams PM (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49. doi:10.1006/abio.1999.4085.
90. McCurley AT, Callard GV (2010) Time Course Analysis of Gene Expression Patterns in Zebrafish Eye During Optic Nerve Regeneration. J Exp Neurosci 2010: 17-33.
91. Wang WL, Liu W, Gong HY, Hong JR, Lin CC, et al. (2011) Activation of cytokine expression occurs through the TNFα/NF-κB-mediated pathway in birnavirus-infected cells. Fish Shellfish Immunol 31: 10-21. doi:10.1016/j.fsi.2011.01.015.
92. Dios S, Romero A, Chamorro R, Figueras A, Novoa B (2010) Effect of the temperature during antiviral immune response ontogeny in teleosts. Fish Shellfish Immunol 29: 1019-1027. doi:10.1016/j.fsi.2010.08.006.
93. Correa RG, Matsui T, Tergaonkar V, Rodriguez-Esteban C, Izpisua-Belmonte JC, et al. (2005) Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB activity. Curr Biol CB 15: 1291-1295. doi:10.1016/j.cub.2005.06.023.
94. Paulus JD, Willer GB, Willer JR, Gregg RG, Halloran MC (2009) Muscle contractions guide rohon-beard peripheral sensory axons. J Neurosci Off J Soc Neurosci 29: 13190-13201. doi:10.1523/JNEUROSCI.2179-09.2009.
95. Schilling TF, Piotrowski T, Grandel H, Brand M, Heisenberg CP, et al. (1996) Jaw and branchial arch mutants in zebrafish I: branchial arches. Dev Camb Engl 123: 329-344.
96. Skarie JM, Link BA (2009) FoxC1 is essential for vascular basement membrane integrity and hyaloid vessel morphogenesis. Invest Ophthalmol Vis Sci 50: 5026-5034. doi:10.1167/iovs.09-3447.
97. Ying H, Yue BYJT (2012) Cellular and molecular biology of optineurin. Int Rev Cell Mol Biol 294: 223-258. doi:10.1016/B978-0-12-394305-7.00005-7.
98. Morton S, Hesson L, Peggie M, Cohen P (2008) Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett 582: 997-1002. doi:10.1016/j.febslet.2008.02.047.
99. Wang C, Hosono K, Ohtsubo M, Ohishi K, Gao J, et al. (2014) Interaction between optineurin and the bZIP transcription factor NRL. Cell Biol Int 38: 16-25. doi:10.1002/cbin.10174.
100. Rogov VV, Suzuki H, Fiskin E, Wild P, Kniss A, et al. (2013) Structural basis for phosphorylation-triggered autophagic clearance of Salmonella. Biochem J 454: 459-466. doi:10.1042/BJ20121907.
101. Buchan DWA, Minneci F, Nugent TCO, Bryson K, Jones DT (2013) Scalable web services for the PSIPRED Protein Analysis Workbench. Nucleic Acids Res 41: W349-357. doi:10.1093/nar/gkt381.
102. Linding R, Jensen LJ, Diella F, Bork P, Gibson TJ, et al. (2003) Protein disorder prediction: implications for structural proteomics. Struct Lond Engl 1993 11: 1453-1459.
103. De Marco N, Buono M, Troise F, Diez-Roux G (2006) Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus. J Biol Chem 281: 16147-16156. doi:10.1074/jbc.M601467200.
104. Rezaie T, Sarfarazi M (2005) Molecular cloning, genomic structure, and protein characterization of mouse optineurin. Genomics 85: 131-138. doi:10.1016/j.ygeno.2004.10.011.
105. Chalasani ML, Radha V, Gupta V, Agarwal N, Balasubramanian D, et al. (2007) A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants. Invest Ophthalmol Vis Sci 48: 1607-1614. doi:10.1167/iovs.06-0834.
106. Kamada M, Izumi Y, Ayaki T, Nakamura M, Kagawa S, et al. (2014) Clinicopathologic features of autosomal recessive amyotrophic lateral sclerosis associated with optineurin mutation. Neuropathol Off J Jpn Soc Neuropathol 34: 64-70. doi:10.1111/neup.12051.
107. Metcalfe WK, Myers PZ, Trevarrow B, Bass MB, Kimmel CB (1990) Primary neurons that express the L2/HNK-1 carbohydrate during early development in the zebrafish. Dev Camb Engl 110: 491-504.
108. Koga T, Shen X, Park JS, Qiu Y, Park BC, et al. (2010) Differential effects of myocilin and optineurin, two glaucoma genes, on neurite outgrowth. Am J Pathol 176: 343-352. doi:10.2353/ajpath.2010.090194.
109. Nakata T, Terada S, Hirokawa N (1998) Visualization of the dynamics of synaptic vesicle and plasma membrane proteins in living axons. J Cell Biol 140: 659-674.
110. Eisen JS, Smith JC (2008) Controlling morpholino experiments: don't stop making antisense. Dev Camb Engl 135: 1735-1743. doi:10.1242/dev.001115.
111. Calkins DJ (2012) Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog Retin Eye Res 31: 702-719. doi:10.1016/j.preteyeres.2012.07.001.
112. Crish SD, Dapper JD, MacNamee SE, Balaram P, Sidorova TN, et al. (2013) Failure of axonal transport induces a spatially coincident increase in astrocyte BDNF prior to synapse loss in a central target. Neuroscience 229: 55-70. doi:10.1016/j.neuroscience.2012.10.069.
113. De Vos KJ, Grierson AJ, Ackerley S, Miller CCJ (2008) Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 31: 151-173. doi:10.1146/annurev.neuro.31.061307.090711.
114. Morfini GA, Bosco DA, Brown H, Gatto R, Kaminska A, et al. (2013) Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase. PloS One 8: e65235. doi:10.1371/journal.pone.0065235.
115. Marinkovic P, Reuter MS, Brill MS, Godinho L, Kerschensteiner M, et al. (2012) Axonal transport deficits and degeneration can evolve independently in mouse models of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 109: 4296-4301. doi:10.1073/pnas.1200658109.
116. Bilsland LG, Sahai E, Kelly G, Golding M, Greensmith L, et al. (2010) Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci U S A 107: 20523-20528. doi:10.1073/pnas.1006869107.
117. Soo KY, Farg M, Atkin JD (2011) Molecular motor proteins and amyotrophic lateral sclerosis. Int J Mol Sci 12: 9057-9082. doi:10.3390/ijms12129057.